JiangSu WuZhong Pharmaceutical Development Co., Ltd.

    JiangSu WuZhong Pharmaceutical Development Co., Ltd.

    SSSE:600200
    0.29
    CNY
    0.00
    (0.00%)
    1,111.04P/E
    JiangSu WuZhong Pharmaceutical Development Co., Ltd.
    SSE:600200
    (Shanghai Stock Exchange)

    Recent

    price

    0.29

    P/E

    ratio

    1,111.04

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    CNY
    3.65
    5.43
    6.15
    5.96
    6.21
    4.88
    4.59
    5.82
    4.11
    2.38
    2.94
    2.62
    2.34
    2.92
    3.11
    2.27
    1.45
    Revenue per Share
    0.02
    0.05
    0.05
    0.08
    0.08
    0.06
    0.08
    0.11
    0.19
    -0.4
    0.09
    -0.71
    0.03
    -0.11
    -0.1
    0.1
    - -
    Basic EPS, GAAP
    0.17
    -0.3
    -0.69
    0.49
    0.16
    -0.64
    -0.03
    0.81
    -0.04
    0.13
    -0.37
    -0.64
    0.56
    0.02
    -0.4
    -0.44
    -0.04
    Free Cash Flow per Basic Share
    0.06
    0.06
    0.16
    0.22
    0.18
    0.2
    0.22
    0.13
    0.09
    0.11
    0.07
    0.09
    0.08
    0.1
    0.09
    0.1
    0.08
    Dividend per Share
    1.1
    1.16
    1.18
    1.27
    1.32
    1.36
    1.46
    1.52
    1.6
    1.16
    1.23
    0.53
    0.49
    0.43
    0.31
    0.42
    0.35
    Book Value per Share
    1.27
    1.34
    1.36
    1.37
    1.47
    1.6
    2.45
    3.49
    3.28
    3.02
    2.91
    2.38
    2.23
    2.34
    2.12
    2.12
    2.04
    Tangible Book Value per Share
    633
    623
    630
    624
    624
    628
    638
    686
    719
    714
    717
    713
    757
    693
    719
    705
    710
    Basic Weighted Avg Shares
    2,309
    3,384
    3,875
    3,723
    3,875
    3,066
    2,928
    3,989
    2,960
    1,702
    2,110
    1,872
    1,775
    2,026
    2,240
    1,599
    1,028
    Sales/Revenue/Turnover
    0.61
    1.41
    1.27
    2.89
    4.88
    5.47
    1.66
    1.81
    4.43
    -2.13
    -0.15
    -1.6
    -1.23
    -0.77
    -1.12
    8.01
    15.28
    Operating Margin (%)
    38
    40
    38
    40
    41
    47
    58
    70
    85
    89
    87
    83
    50
    48
    46
    50
    - -
    Depreciation Expense
    15
    29
    31
    47
    51
    41
    49
    72
    133
    -286
    65
    -506
    23
    -76
    -72
    70
    2
    Net Income, GAAP
    30.87
    24.67
    26.84
    34.57
    37.85
    34.68
    26.26
    - -
    26.31
    - -
    20.09
    - -
    47.4
    - -
    - -
    - -
    20.46
    Effective Tax Rate (%)
    0.63
    0.87
    0.8
    1.26
    1.3
    1.33
    1.68
    1.8
    4.5
    -16.78
    3.06
    -27.06
    1.28
    -3.76
    -3.21
    4.41
    0.16
    Profit Margin (%)
    75
    672
    709
    478
    433
    627
    1,403
    1,085
    1,042
    627
    614
    1,084
    989
    874
    622
    948
    893
    Working Capital
    20
    189
    327
    258
    235
    340
    426
    88
    88
    87
    115
    230
    168
    165
    141
    195
    195
    LT Debt
    890
    992
    1,010
    1,008
    1,068
    1,139
    1,702
    2,968
    2,931
    2,408
    2,363
    1,852
    1,877
    1,824
    1,761
    1,889
    1,848
    Total Equity
    0.63
    2.13
    1.62
    2.86
    4.76
    4.06
    1.16
    - -
    2.44
    - -
    -0.08
    - -
    -0.36
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    2.37
    3.2
    2.41
    2.59
    1.63
    1.78
    3.01
    - -
    7.65
    - -
    5.89
    - -
    3.44
    - -
    - -
    - -
    7.25
    Return on Capital (%)
    2.11
    4.12
    4.2
    6.1
    6.25
    4.87
    5.5
    7.28
    12.12
    -28.8
    7.54
    -80.35
    6.07
    -22.84
    -27.69
    27.22
    0.65
    Return on Common Equity (%)

    Capital Structure

    CNY

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    ST Debt
    1,452
    1,414
    1,373
    LT Borrowings
    181
    203
    182
    LT Finance Leases
    14
    13
    12
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    712
    712
    712
    Market Capitalization
    6,736
    3,757
    1,790

    Working Capital

    CNY

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    Total Current Assets
    2,753
    2,755
    2,651
    Cash, Cash Equivalents & STI
    1,152
    168
    110
    Accounts Receivable, Net
    1,296
    2,171
    2,140
    Inventories
    94
    95
    78
    Total Current Liabilities
    1,805
    1,865
    1,758
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    1,452
    1,414
    1,373
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CNY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    8.36%
    -3.86%
    7.24%
    Free Cash Flow
    -594.15%
    -454.71%
    8.28%
    Net Income, GAAP
    -191.4%
    -325.72%
    -197.97%
    Sales/Revenue/Turnover
    -3.3%
    -4.08%
    -28.64%
    Total Cash Common Dividend
    -3.62%
    5.67%
    -0.09%

    Quarterly Revenue

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    612
    489
    403
    737
    2,240
    2024
    425
    503
    441
    -49
    1,599
    2025
    317
    319
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.04
    - -
    - -
    - -
    -0.1
    2024
    0.01
    - -
    - -
    - -
    0.1
    2025
    -0.1
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.02
    - -
    - -
    - -
    0.09
    2024
    0.03
    - -
    - -
    - -
    0.1
    2025
    0.02
    - -
    - -
    - -
    - -
    Similar Companies
    Business